Navigation Links
Medivation Presents New Data on Dimebon's Novel Mechanism of Action
Date:12/9/2008

al mechanism of action may account for the clinical benefit observed in the Dimebon Alzheimer's and Huntington's disease clinical trials completed to date.

About Dimebon

Dimebon is an oral small molecule in development with Pfizer for Alzheimer's and Huntington's diseases. It is currently being evaluated in a second pivotal Phase 3 trial in Alzheimer's disease. Results from the first pivotal trial were published in the July 19, 2008, edition of The Lancet. A Phase 2 study in Huntington's disease was recently completed, and further development is planned in Huntington's disease.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. In September 2008, Medivation entered into a global agreement with Pfizer Inc to develop and commercialize Dimebon for the treatment of Alzheimer's and Huntington's diseases. With Pfizer, the Company is conducting a broad Dimebon clinical development program, including a pivotal and confirmatory Phase 3 trial, known as the CONNECTION study, in patients with mild-to-moderate Alzheimer's disease. The program also includes additional trials planned to begin next year in Alzheimer's disease, as well as further development of Dimebon in patients with mild-to-moderate Huntington's disease. In addition, a Phase 1-2 clinical trial of MDV3100 in patients with castration-resistant (also known as hormone-refractory) prostate cancer is ongoing. For more information, please visit us at http://www.medivation.com.

This press release contains forward-looking statements, including statements regarding the mechanism of action of Dimebon, the p
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Medivation Announces Participation in RBC Capital Markets 2008 Healthcare Conference
2. Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
3. Medivation Announces Third Quarter 2008 Teleconference and Webcast on November 10, 2008
4. Medivation Announces Expiration of Hart-Scott-Rodino Waiting Period for Collaboration With Pfizer
5. Medivation Announces Presentation of 24-Week Clinical Data of MDV3100 in Castration-Resistant Prostate Cancer Patients
6. Medivation Receives Corporate Achievement Award From Huntingtons Disease Society of America
7. Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Partnering Plans for Dimebon
8. Medivation Announces Participation in Upcoming Conferences
9. Medivation Reports Second Quarter 2008 Financial Results and Provides Corporate Update
10. Medivation Announces Second Quarter 2008 Teleconference and Webcast on August 11, 2008
11. Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... The New York investment bank KTA Capi...has agreed an AU$6.7 mil convertible note private ...private placement was arranged by KTA Capital as N... New York (PRWEB) November ...nk KTA Capital, LLC ("KTA Capital") has ...
(Date:11/24/2009)...AVIK,Iceland,November24/PRNewswire-FirstCall/--deC...ithasreceivednoticefrom,theNasdaqStockMarketthattr...November30,2009andaForm25-NSEwillbefiledwiththe,Se...E,scommonstock,fromlistingonNasdaq,unlessthecompan...el.Thecompanyhasfiledsuchanappeal,which,willstayth...
(Date:11/24/2009)...AVIK,Iceland,November24/PRNewswire-FirstCall/--deC...pprovalofallofits,"firstday"motionsbytheU.S.Bankru...ourt").deCODElastweekfiledavoluntarypetitionfor,re...iththe,BankruptcyCourt. , Theordersissuedbyth...eitsbusinessduringtheChapter11proceedings.Inpartic...
(Date:11/24/2009)...HAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyannoun...A)hasapprovedthe,investigationalnewdrugapplication...einsulinformulationtotreatdiabetes.ThisIND,approva...y. , Diabetesisadisordercharacteristicofhighb...abetesoftenresultinseveremicro-and,macro-vasculard...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2
...are in U.S. dollars, QUEBEC CITY, May 7 /PRNewswi...ZS , TSX: AEZ), a global biopharmaceutical company...rted financial and operating results,for the first...08 Highlights, - Cetrorelix: first patients treat...ram in benign prostatic hyperplasia (BPH); - AEZS...
...notubes potential as a super material is blighted... the form of an unprepossessing pile of sooty blac...rs in the University of Warwicks Department of Che...bes in which they instantly form a highly sensitiv... just been published in a paper entitled Single-Wa...
...io, May 6 Developing a strong,pharmaceutical indu...telle-Korea, Battelle, Chuncheon City, Gangwon Pro...ess the issue. A Korean corporation named,Internat...med to develop a,bioequivalency business in Chunch...tional Good Laboratory Practices (GLP) standards.,...
Other Biology Technology:AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 2AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 3AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 4AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 5AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 6AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results 7Nanotube production leaps from sooty mess in test tube to ready formed chemical microsensors 2Battelle Collaborating With Korean Partners to Advance Energy Efficiency and Health and Life Sciences Initiatives in Korea 2
(Date:11/24/2009)... This release is available in Spanish . , T...igher levels of inflammatory substances in the blo...t; as shown by a research project of the Universit..., a scientist at the School of Pharmacy. , The p...study in relation to the control of body weight an...
(Date:11/23/2009)... A new study by the Wildlife Conservation Society...rge swamp in the Republic of Congopart of the "mot... last yearare becoming increasingly threatened by ...dy recommends protection of the swamp forests adja...eserve after recent surveys confirmed that high de...
(Date:11/23/2009)...LIVERMORE, Calif. - By producing some of the highe...ral surfaces, scientists have a deeper understandi.... This research may lead to a new treatment for ki...which appears in the Nov. 23 online edition of the...ciences , explores how peptides interact with mine...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Poor Restroom Cleaning Causes Cruise Ship Sickness 60833 1Poor Restroom Cleaning Causes Cruise Ship Sickness 60833 2Can a Bad Boss Make You Sick 3F 60831 1Can a Bad Boss Make You Sick 3F 60831 2New Energy Spray Uses Capsaicin to Deliver Caffeine for Sustained Mental Focus 60829 1New Energy Spray Uses Capsaicin to Deliver Caffeine for Sustained Mental Focus 60829 2
...s are more dramatic than when they band together a...ples are the many thousands of wildebeests and oth...ss the African plains. , Countless millions of M...nite with their own kind and form teeming, hungry ...th that,s edible. Some spectacular marching packs ...
...ell migration, the movement of cells within the bo...une response to invading pathogens, has been demon...rnia, San Diego (UCSD) School of Medicine. Publish...iology and the journal,s upcoming April print edit...alpha4 integrin adhesion receptor with a protein c...
...How nature wraps and tags genes determines if and ...from Harvard and the Massachusetts Institute of Te...iled study to date of the protein structure that s... surprising and previously unknown specifics of ho...human body and in diseases such as cancer. , "Eac...
Other Biology News:Experiments provide proof of how traveling in groups protects insects 2Vital step in cellular migration described by UCSD medical researchers 2Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease 2Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease 3
...Se Kit delivers a novel procedure for the uniform ...) labeling of whole genome DNA from small samples....and highly reproducible amplification and labeling...sists of a REPLI-g Mini Kit module (QIAGEN) and a ...
Cellomics KineticScan HCS Reader from Beckman Coulter
...f a protein into cells permits studies of protein-...ling pathways, apoptotic pathways, and transcripti... method for studying the effects of a specific pro...in directly into the cell. ProteoJuice Protein Tra...
...innovative reagent for highly efficient transfer o...ells. Unlike DNA transfection, with PULSin Protein... of exogenous proteins in cells can be controlled,...me function blocking and protein localization stud...
Biology Products: